Tonix Pharmaceuticals Holding Corp expected to post a loss of $2.57 a share - Earnings Preview

Reuters03-13 19:00
Tonix Pharmaceuticals Holding Corp <tnxp.oq> expected to post a loss of $2.57 a share - Earnings Preview </tnxp.oq>

  • Tonix Pharmaceuticals Holding Corp TNXP.OQ TNXP.O is expected to show a rise in quarterly revenue when it reports results on March 16 (estimated) for the period ending March 31 2026

  • The Chatham New Jersey-based company is expected to report a 433.1% increase in revenue to $12.95 million from $2.43 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Tonix Pharmaceuticals Holding Corp is for a loss of $2.57 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 6.8% in the last three months. ​

  • Wall Street's median 12-month price target for Tonix Pharmaceuticals Holding Corp is $65.00, about 384.7% above its last closing price of $13.41

This summary was machine generated March 13 at 11:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment